Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Find out which gas rewards card is best with no fee. Get insights to help you choose the right card for savings.
22,605 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Bitcoin dropped below the $67,000 level as U.S. Treasury yields climbed toward yearly highs, igniting a risk-off shak...
President Trump issues an emergency payroll directive for TSA workers as the DHS shutdown drags on, hoping to relieve...
Gold and silver surged as hopes for a US–Iran deal cooled inflation pressures and a softer dollar sparked a shift int...
A new Grok AI forecast signals a measured gain for Bitcoin, Ethereum, and XRP through May 2026, with upside contingen...
Kick off your week with a curated list of investing insights. These Monday reads translate market noise into actionab...
As Warren Buffett's successor, Greg Abel has begun steering Berkshire Hathaway's portfolio with careful turns. A nota...
Deere set to pay a $1.62 quarterly dividend on May 8, 2026, keeping the payout flat for several quarters as investors...
A 50-year-old professional earning $210,000 unveils a four-account plan to craft tax-free retirement income by 62, bl...
Unlock the meaning behind the natr 2026 earnings transcript. Learn how to parse numbers, gauge management guidance, a...
A celebrity legal shock isn’t just a headline—it can ripple through finances. This article breaks down practical step...
Looking ahead to 2026, investors want a clear view of how Global Partners will navigate energy markets, margins, and ...